Moomoo AI 已提取核心信息
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的帕特里克·伯内特于2024年3月4日完成了公司股票的出售。该交易涉及以每股11.1212美元的价格出售4,782股普通股。出售后，伯内特在该公司的直接持股量为269,300股。出售的股票的总价值约为53,181.58美元。此次出售是在公开市场上执行的，是正常投资交易过程的一部分。
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的帕特里克·伯内特于2024年3月4日完成了公司股票的出售。该交易涉及以每股11.1212美元的价格出售4,782股普通股。出售后，伯内特在该公司的直接持股量为269,300股。出售的股票的总价值约为53,181.58美元。此次出售是在公开市场上执行的，是正常投资交易过程的一部分。
有用
没用